Literature DB >> 7523178

Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.

E J Mufson1, J S Kroin, T Sobreviela, M A Burke, J H Kordower, R D Penn, J A Miller.   

Abstract

The pattern of retrogradely transported BDNF, a member of the nerve growth family of neurotrophins, following intrastriatal infusion was immunohistochemically visualized within the rodent central nervous system. Human recombinant BDNF was infused at a rate of 3 micrograms/h for 7 days with an Alzet 2002 minipump prior to sacrifice. Tissue immunohistochemically processed using a turkey anti-BDNF antibody revealed retrogradely transported BNDF within neurons located mainly within the ipsilateral frontoparietal cortex (predominantly layer V), parafascicular and posterior thalamic nuclei, and substantia nigra, pars compacta. Sections dual immunoreacted for BNNF and tyrosine hydroxylase revealed a subpopulation of dopaminergic neurons (approximately 28%) within the pars compacta which contained retrogradely transported BDNF. Experiments in which a mixture of BDNF and the retrograde tracer fluorogold were simultaneously infused for 7 days into the striatum revealed BDNF and fluorogold single-labeled neurons as well as BDNF and fluorogold dual-labeled cells within the substantia nigra, pars compacta. These observations indicate that only a subpopulation of neurons within the substantia nigra retrogradely transport BDNF following intrastriatal infusion and thus only a subpopulation of cells may be responsive to the trophic influences of BDNF. The retrograde transport of trophins, such as BDNF, represents a unique neuroanatomical tool to selectivity map the location of specific neurotrophin-responsive systems. Unraveling the trophic anatomy of BDNF will aid in understanding its role in development, degeneration, and experimental animal models of regeneration providing essential data for its use in clinical neurodegenerative disorders including Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523178     DOI: 10.1006/exnr.1994.1143

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

1.  Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.

Authors:  Heath D Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

2.  Chronic cigarette smoke exposure enhances brain-derived neurotrophic factor expression in rats with traumatic brain injury.

Authors:  I-Neng Lee; Martin Hsiu-Chu Lin; Chiu-Yen Chung; Ming-Hsueh Lee; Hsu-Huei Weng; Jen-Tsung Yang
Journal:  Metab Brain Dis       Date:  2012-04-03       Impact factor: 3.584

3.  Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.

Authors:  Y S Lau; R Hao; Y K Fung; L S Fu; J F Bishop; R F Pfeiffer; M M Mouradian
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

Review 4.  The lighter side of BDNF.

Authors:  Emily E Noble; Charles J Billington; Catherine M Kotz; ChuanFeng Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

5.  Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.

Authors:  Simona Capsoni; Cecilia Tiveron; Domenico Vignone; Gianluca Amato; Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.

Authors:  B A Horger; C A Iyasere; M T Berhow; C J Messer; E J Nestler; J R Taylor
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

7.  Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward.

Authors:  Danielle L Graham; Vaishnav Krishnan; Erin B Larson; Ami Graham; Scott Edwards; Ryan K Bachtell; Diana Simmons; Lana M Gent; Olivier Berton; Carlos A Bolanos; Ralph J DiLeone; Luis F Parada; Eric J Nestler; David W Self
Journal:  Biol Psychiatry       Date:  2008-11-06       Impact factor: 13.382

8.  TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin.

Authors:  T Sobreviela; D O Clary; L F Reichardt; M M Brandabur; J H Kordower; E J Mufson
Journal:  J Comp Neurol       Date:  1994-12-22       Impact factor: 3.215

Review 9.  Update of neurotrophic factors in neurobiology of addiction and future directions.

Authors:  Maryna Koskela; Susanne Bäck; Vootele Võikar; Christopher T Richie; Andrii Domanskyi; Brandon K Harvey; Mikko Airavaara
Journal:  Neurobiol Dis       Date:  2016-05-14       Impact factor: 5.996

Review 10.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.